The Spt-Ada-Gcn5-acetyltransferase complex interaction motif of E2a is essential for a subset of transcriptional and oncogenic properties of E2a-Pbx1

Leukemia and Lymphoma

Volumn 50, Issue 5, 2009, Pages 816-828

  Scheele, Jürgen S ^a   Kolanczyk, Mateusz ^a   Gantert, Melanie ^a   Zemojtel, Tomasz ^a   Dorn, Annette ^a   Sykes, David P ^b   Möbest, Dietrich C C ^a   Kamps, Mark P ^b   Räpple, Daniel ^a   Duchniewicz, Marlena ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

E2a Pbx1; EF 9; Leukemia; Transcription

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 15; HETERODIMER; HISTONE ACETYLTRANSFERASE; HOMODIMER; HOX PROTEIN; LEUKEMIA CELL DERIVED SUPPRESSOR FACTOR; MEMBRANE PROTEIN; PROTEIN EF 9; SUPPRESSOR FACTOR; TRANSCRIPTION FACTOR E2A; TRANSCRIPTION FACTOR PBX1; TRANSCRIPTION FACTOR SAGA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; GENE ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTRON; MOUSE; MUTATIONAL ANALYSIS; MYELOID PROGENITOR CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION;

AMINO ACID MOTIFS; ANIMALS; BASE SEQUENCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; DNA-BINDING PROTEINS; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE ACETYLTRANSFERASES; HOMEODOMAIN PROTEINS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MYELOID CELLS; NIH 3T3 CELLS; ONCOGENE PROTEINS, FUSION; PEPTIDE ELONGATION FACTOR 2; PROTO-ONCOGENE PROTEINS; TRANSCRIPTIONAL ACTIVATION;

EID: 68449092514     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190902836107     Document Type: Article

References (36)

1. Bain G, Romanow WJ, Albers K, Havran WL, Murre C. Positive and negative regulation of V(D)J recombination by the E2A proteins. J Exp Med 1999;189:289-300.
2. McMurry MT, Krangel MS. A role for histone acetylation in the developmental regulation of VDJ recombination. Science 2000;287:495-498.
3. Massari ME, Grant PA, Pray-Grant MG, Berger SL, Workman JL, Murre C. A conserved motif present in a class of helix-loop-helix proteins activates transcription by direct recruitment of the SAGA complex. Mol Cell 1999;4: 63-73.
4. Eckner R, Yao TP, Oldread E, Livingston DM. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes Dev 1996;10: 2478-2490.
5. Qiu Y, Sharma A, Stein R. p300 mediates transcriptional stimulation by the basic helix-loop-helix activators of the insulin gene. Mol Cell Biol 1998;18:2957-2964.
6. Inaba T, Roberts WM, Shapiro LH, Jolly KW, Raimondi SC, Smith SD, et al. Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Science 1992;257:531-534.
7. Kamps MP, Look AT, Baltimore D. The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2APbx1 fusion proteins with differing transforming potentials. Genes Dev 1991;5:358-368.
8. Van Dijk MA, Voorhoeve PM, Murre C. Pbx1 is converted into a transcriptional activator upon acquiring the N-terminal region of E2A in pre-B-cell acute lymphoblastoid leukemia. Proc Natl Acad Sci USA 1993;90:6061-6065.
9. Lu Q, Wright DD, Kamps MP. Fusion with E2A converts the Pbx1 homeodomain protein into a constitutive transcriptional activator in human leukemias carrying the t(1;19) translocation. Mol Cell Biol 1994;14:3938-3948.
10. Monica K, LeBrun DP, Dedera DA, Brown R, Cleary ML. Transformation properties of the E2a-Pbx1 chimeric oncoprotein: Fusion with E2a is essential, but the Pbx1 homeodomain is dispensable. Mol Cell Biol 1994;14:8304- 8314.
11. Redner RL, Wang J, Liu JM. Chromatin remodeling and leukemia: New therapeutic paradigms. Blood 1999;94:417- 428.
12. Rebel VI, Kung AL, Tanner EA, Yang H, Bronson RT, Livingston DM. Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. Proc Natl Acad Sci USA 2002;99:14789-14794.
13. Giordano A, Avantaggiati ML. p300 and CBP: Partners for life and death. J Cell Physiol 1999;181:218-230.
14. Kamps MP, Wright DD, Lu Q. DNA-binding by oncoprotein E2a-Pbx1 is important for blocking differentiation but dispensable for fibroblast transformation. Oncogene 1996;12: 19-30.
15. Monica K, LeBrun DP, Dedera DA, Brown R, Cleary ML. Transformation properties of the E2a-Pbx1 chimeric oncoprotein: Fusion with E2a is essential, but the Pbx1 homeodomain is dispensable. Mol Cell Biol 1994;14:8304-8314.
16. Bayly R, LeBrun DP. Role for homodimerization in growth deregulation by E2a fusion proteins. Mol Cell Biol 2000;20: 5789-5796.
17. Bork P, Sander C. A large domain common to sperm receptors (Zp2 and Zp3) and TGF-beta type III receptor. FEBS Lett 1992;300:237-240.
18. Lambert C, Brealey R, Steele J, Rook GA. The interaction of Tamm-Horsfall protein with the extracellular matrix. Immunology 1993;79:203-210.
19. Muchmore AV, Decker JM. Evidence that recombinant IL 1 alpha exhibits lectin-like specificity and binds to homogeneous uromodulin via N-linked oligosaccharides. J Immunol 1987; 138:2541-2546.
20. Sherblom AP, Decker JM, Muchmore AV. The lectin-like interaction between recombinant tumor necrosis factor and uromodulin. J Biol Chem 1988;263:5418-5424.
21. Yamashita T, Yoshioka M, Itoh N. Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem Biophys Res Commun 2000;277:494-498.
22. McWhirter JR, Goulding M, Weiner JA, Chun J, Murre C. A novel fibroblast growth factor gene expressed in the developing nervous system is a downstream target of the chimeric homeodomain oncoprotein E2A-Pbx1. Development 1997; 124:3221-3232.
23. Itoh N, Ornitz DM. Functional evolutionary history of the mouse Fgf gene family. Dev Dyn 2008;237:18-27.
24. Vincentz JW, McWhirter JR, Murre C, Baldini A, Furuta Y. Fgf15 is required for proper morphogenesis of the mouse cardiac outflow tract. Genesis 2005;41:192-201.
25. Inagaki T, Choi M, Moschetta A, Peng L, Cummins CL, McDonald JG, et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2005;2:217-225.
26. Calvo KR, Knoepfler P, McGrath S, Kamps MP. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1. Oncogene 1999;18:8033-8043.
27. Sykes DB, Kamps MP. Estrogen-dependent E2a/Pbx1 myeloid cell lines exhibit conditional differentiation that can be arrested by other leukemic oncoproteins. Blood 2001;98: 2308-2318.
28. Fu X, Kamps MP. E2a-Pbx1 induces aberrant expression of tissue-specific and developmentally regulated genes when expressed in NIH 3T3 fibroblasts. Mol Cell Biol 1997;17: 1503-1512.
29. Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci USA 1984;81:1991-1995.
30. Knoepfler PS, Lu Q, Kamps MP. Pbx-1 Hox heterodimers bind DNA on inseparable half-sites that permit intrinsic DNA binding specificity of the Hox partner at nucleotides 30 to a TAAT motif. Nucleic Acids Res 1996;24:2288-2294.
31. Daley GQ, Van Etten RA, Baltimore D. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 1990;247:824-830.
32. Gesteland RF, Atkins JF. Recoding: Dynamic reprogramming of translation. Annu Rev Biochem 1996;65:741-768.
33. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, et al. Initial sequencing and comparative analysis of the mouse genome. Nature 2002;420:520-562.
34. Nielsen H, Engelbrecht J, Brunak S, von Heijne G. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng 1997;10: 1-6.
35. Neuteboom ST, Murre C. Pbx raises the DNA binding specificity but not the selectivity of antennapedia Hox proteins. Mol Cell Biol 1997;17:4696-4706.
36. Ron D, Tronick SR, Aaronson SA, Eva A. Molecular cloning and characterization of the human dbl proto-oncogene: Evidence that its overexpression is sufficient to transform NIH/3T3 cells. EMBO J 1988;7:2465-2473.